Literature DB >> 9506558

Mutations in all five exons of SOD-1 may cause ALS.

C E Shaw1, Z E Enayat, B A Chioza, A Al-Chalabi, A Radunovic, J F Powell, P N Leigh.   

Abstract

Eight of 38 patients (21%) with familial and 5 of 175 patients (3%) with sporadic amyotrophic lateral sclerosis (ALS) had missense mutations in the SOD-1 gene. Two novel mutations were identified. One in exon 4 substituting leucine with phenylalanine (L84F) in a familial patient and the second in exon 3 at substituting glycine with serine (G72S) in an "apparently" sporadic patient. Over 60 point mutations have now been described in all five exons of SOD-1, involving 43 of the 153 residues. Hypotheses about the toxic role of mutant SOD-1 in the pathogenesis of ALS must account for this molecular diversity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506558     DOI: 10.1002/ana.410430319

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

Review 1.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

2.  Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q.

Authors:  Deborah M Ruddy; Matthew J Parton; Ammar Al-Chalabi; Cathryn M Lewis; Caroline Vance; Bradley N Smith; P Nigel Leigh; John F Powell; Teepu Siddique; Eelco Postumus Meyjes; Frank Baas; Vianney de Jong; Christopher E Shaw
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

3.  The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families.

Authors:  Malessa Rabe; Ansgar Felbecker; Stefan Waibel; Peter Steinbach; Pia Winter; Ulrich Müller; Albert C Ludolph
Journal:  J Neurol       Date:  2010-03-23       Impact factor: 4.849

4.  Amyotrophic lateral sclerosis in a patient with a family history of huntington disease: genetic counseling challenges.

Authors:  Andrea L Smith; James W Teener; Brian C Callaghan; Jack Harrington; Wendy R Uhlmann
Journal:  J Genet Couns       Date:  2014-04-26       Impact factor: 2.537

Review 5.  Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.

Authors:  Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

Review 6.  Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  S Cluskey; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

Review 7.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

8.  Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms.

Authors:  J Roy; S Minotti; L Dong; D A Figlewicz; H D Durham
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.

Authors:  Yoshinori Nishimoto; Daisuke Ito; Takuya Yagi; Yoshihiro Nihei; Yoshiko Tsunoda; Norihiro Suzuki
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

Review 10.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.